IDYA vs. ELEV

In the year-to-date period, IDYA achieves a -28.08% return, which is significantly lower than ELEV's 16.39% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Elevation Oncology Inc (ELEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IDYA Sharpe Ratio is -0.57, which is lower than the ELEV Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of IDYA and ELEV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither IDYA nor ELEV has paid dividends to shareholders.

The maximum IDYA drawdown since its inception was -74.64%, smaller than the maximum ELEV drawdown of -97.64%. Use the drawdown chart below to compare losses from any high point for IDYA and ELEV. For additional features, visit the drawdowns tool.

The current volatility for IDEAYA Biosciences, Inc. (IDYA) is 14.82%, while Elevation Oncology Inc (ELEV) has a volatility of 24.26%. This indicates that IDYA experiences smaller price fluctuations and is considered to be less risky than ELEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Elevation Oncology Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.